• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ocugen, Inc. - Common Stock (NQ:OCGN)

    1.510 +0.030 (+2.03%)
    Streaming Delayed Price Updated: 1:43 PM EDT, Jul 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,250,520
    Open 1.510
    Bid (Size) 1.500 (67,200)
    Ask (Size) 1.510 (10,300)
    Prev. Close 1.480
    Today's Range 1.495 - 1.600
    52wk Range 0.9029 - 2.725
    Shares Outstanding 257,328,085
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Ocugen to Participate in Upcoming July Industry Conferences
    From Ocugen
    Via GlobeNewswire
    News headline image
    Ocugen to Participate in Upcoming June Investor and Industry Conferences
    From Ocugen
    Via GlobeNewswire

    Performance

    YTD
    +9.4%
    +9.4%
    1 Month
    +10.2%
    +10.2%
    3 Month
    -15.6%
    -15.6%
    6 Month
    +11.9%
    +11.9%
    1 Year
    +63.4%
    +63.4%

    More News

    Read More
    News headline image
    Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes
    From Ocugen
    Via GlobeNewswire
    News headline image
    3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
    Via The Motley Fool
    Ocugen (NASDAQ:OCGN) Beats Q1 Revenue Estimates but Widens Net Loss, Announces $115M Capital Raise to Fund Pipeline Through 2028 ↗
    Via Chartmill
    Ocugen Inc (NASDAQ:OCGN) Stock Drops 7% on Q4 Revenue Miss, Highlights Clinical Pipeline ↗
    Via Chartmill
    News headline image
    Ocugen to Participate in Upcoming May Scientific and Investor Conferences
    From Ocugen
    Via GlobeNewswire
    News headline image
    Ocugen Provides Business Update with First Quarter 2026 Financial Results
    From Ocugen
    Via GlobeNewswire
    News headline image
    Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes
    From Ocugen
    Via GlobeNewswire
    Top movers in Monday's after hours session ↗
    Via Chartmill
    News headline image
    Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
    From Ocugen
    Via GlobeNewswire
    News headline image
    Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
    From Ocugen
    Via GlobeNewswire
    News headline image
    Ocugen to Present at April 2026 Investor and Industry Conferences
    From Ocugen
    Via GlobeNewswire
    News headline image
    Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
    From Ocugen
    Via GlobeNewswire
    News headline image
    Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
    From Ocugen
    Via GlobeNewswire
    News headline image
    Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy
    From Ocugen
    Via GlobeNewswire
    News headline image
    OCGN Stock Rallies On Wall Street Optimism For Clinical Pipeline: Retail Awaits New Data ↗
    Via Stocktwits
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    Top movers in Wednesday's session ↗
    Via Chartmill
    News headline image
    Ocugen (OCGN) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
    From Ocugen
    Via GlobeNewswire
    News headline image
    Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
    Via FinancialNewsMedia
    News headline image
    Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
    From Ocugen
    Via GlobeNewswire
    News headline image
    Why Did OCGN Stock Rise Today? ↗
    Via Stocktwits
    News headline image
    Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2025 Financial Results
    From Ocugen
    Via GlobeNewswire

    Frequently Asked Questions

    Is Ocugen, Inc. - Common Stock publicly traded?
    Yes, Ocugen, Inc. - Common Stock is publicly traded.
    What exchange does Ocugen, Inc. - Common Stock trade on?
    Ocugen, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ocugen, Inc. - Common Stock?
    The ticker symbol for Ocugen, Inc. - Common Stock is OCGN on the Nasdaq Stock Market
    What is the current price of Ocugen, Inc. - Common Stock?
    The current price of Ocugen, Inc. - Common Stock is 1.510
    When was Ocugen, Inc. - Common Stock last traded?
    The last trade of Ocugen, Inc. - Common Stock was at 07/02/26 01:43 PM ET
    What is the market capitalization of Ocugen, Inc. - Common Stock?
    The market capitalization of Ocugen, Inc. - Common Stock is 388.57M
    How many shares of Ocugen, Inc. - Common Stock are outstanding?
    Ocugen, Inc. - Common Stock has 389M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.